Mar 21, 2017 4:55pm EDT Adaptimmune Therapeutics plc Proposes Public Offering of American Depositary Shares
Mar 08, 2017 8:00am EST Adaptimmune to Report Fourth Quarter and Full Year 2016 Financial Results on March 13, 2017
Mar 02, 2017 8:00am EST Adaptimmune to Present at the Cowen and Company 37th Annual Health Care Conference
Mar 01, 2017 8:30am EST Adaptimmune Cuts Ribbon on U.S. Headquarters at the Navy Yard in Philadelphia
Jan 09, 2017 8:01am EST Adaptimmune confirms GSK Nomination of Second Adaptimmune Target under Strategic Multi-Target Collaboration
Jan 09, 2017 8:01am EST Adaptimmune Announces New Senior Vice President of Global Bio-Process and Development
Jan 09, 2017 8:00am EST Adaptimmune Announces FDA Acceptance of IND Application for Affinity Enhanced T-Cell Therapy Targeting MAGE-A4 in Multiple Solid Tumors
